Autoinflammatory bone disorders

Clinical Immunology

Volumn 147, Issue 3, 2013, Pages 185-196

  Morbach, Henner ^a   Hedrich, Christian M ^b   Beer, Meinrad ^a,c   Girschick, Hermann J ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Children's Hospital   (Germany)

Author keywords

Autoinflammation; Cherubism; Chronic non bacterial osteomyelitis; Chronic recurrent multifocal osteomyelitis; Hypophosphatasia; Primary hypertrophic osteoarthropathy

Indexed keywords

AUTOINFLAMMATORY DISEASE; BONE DISEASE; BONE METABOLISM; CHRONIC OSTEOMYELITIS; FIBROUS DYSPLASIA; HUMAN; HYPOPHOSPHATASIA; JUVENILE RHEUMATOID ARTHRITIS; MAJEED SYNDROME; NONHUMAN; OSTEOARTHROPATHY; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPONDYLOARTHROPATHY; ANIMAL; CHRONIC DISEASE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; GENETIC PREDISPOSITION; GENETICS; HEREDITARY PERIODIC FEVER; IMMUNOLOGY; INFLAMMATION; MOUSE; OSTEOMYELITIS; RARE DISEASE;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ANIMALS; BONE DISEASES; BONE RESORPTION; CHERUBISM; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; HYPOPHOSPHATASIA; INFLAMMATION; MICE; OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC; OSTEOMYELITIS; RARE DISEASES;

EID: 84882274525     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.12.012     Document Type: Review

References (97)

1. S.L. Masters, A. Simon, I. Aksentijevich, D.L. Kastner, Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease, Annu. Rev. Immunol. 27 (1) (Apr. 2009) 621-668.
2. P.J. Ferguson, H.I. El-Shanti, Autoinflammatory bone disorders, Curr. Opin. Rheumatol. 19 (5) (Sep. 2007) 492-498.
3. H.J. Girschick, C. Zimmer, G. Klaus, K. Darge, A. Dick, H. Morbach, Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat. Clin. Pract. Rheumatol. 3 (12) (Dec. 2007) 733-738.
4. H. Takayanagi, Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems, Nat. Rev. Immunol. 7 (4) (Apr. 2007) 292-304.
5. H.J. Girschick, P. Raab, S. Surbaum, A. Trusen, S. Kirschner, P. Schneider, T. Papadopoulos, H.K. Müller-Hermelink, P.E. Lipsky, Chronic non-bacterial osteomyelitis in children, Ann. Rheum. Dis. 64 (2) (Feb. 2005) 279-285.
6. A. Jansson, E.D. Renner, J. Ramser, A. Mayer, M. Haban, A. Meindl, V. Grote, J. Diebold, V. Jansson, K. Schneider, B.H. Belohradsky, Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients, Rheumatology (Oxford) 46 (1) (Jan. 2007) 154-160.
7. J. Wipff, C. Adamsbaum, A. Kahan, C. Job-Deslandre, Chronic recurrent multifocal osteomyelitis, Joint Bone Spine 78 (6) (Dec. 2011) 555-560.
8. P.D. Gikas, L. Islam, W. Aston, R. Tirabosco, A. Saifuddin, T.W.R. Briggs, S.R. Cannon, P. O'Donnell, B. Jacobs, A.M. Flanagan, Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis, J. Orthop. Sci. 14 (5) (Sep. 2009) 505-516.
9. C. Schultz, P.M. Holterhus, A. Seidel, S. Jonas, M. Barthel, K. Kruse, P. Bucsky, Chronic recurrent multifocal osteomyelitis in children, Pediatr. Infect. Dis. J. 18 (11) (Nov. 1999) 1008-1013.
10. H.J. Girschick, H.I. Huppertz, D. Harmsen, R. Krauspe, H.K. Müller-Hermelink, T. Papadopoulos, Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing, Hum. Pathol. 30 (1) (Jan. 1999) 59-65.
11. H. Morbach, A. Dick, C. Beck, M. Stenzel, H.K. Müller-Hermelink, P. Raab, H.J. Girschick, Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants, Rheumatol. Int. 30 (5) (Jul. 2009) 617-621.
12. C. Job-Deslandre, S. Krebs, A. Kahan, Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases, Joint Bone Spine 68 (3) (May 2001) 245-251.
13. A.M. Huber, P.-Y. Lam, C.M. Duffy, R.S.M. Yeung, M. Ditchfield, D. Laxer, W.G. Cole, H. Kerr Graham, R.C. Allen, R.M. Laxer, Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up, J. Pediatr. 141 (2) (Aug. 2002) 198-203.
14. C.J. Omidi, E.C. Siegfried, Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient, Pediatr. Dermatol. 15 (6) (Oct. 1998) 435-438.
15. A. Bousvaros, M. Marcon, W. Treem, P. Waters, R. Issenman, R. Couper, R. Burnell, A. Rosenberg, E. Rabinovich, B.S. Kirschner, Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children, Dig. Dis. Sci. 44 (12) (Dec. 1999) 2500-2507.
16. B.E. Tlougan, J.O. Podjasek, J. O'Haver, K.B. Cordova, X.H. Nguyen, R. Tee, K.C. Pinckard-Hansen, R.C. Hansen, Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature, Pediatr. Dermatol. 26 (5) (Aug. 2009) 497-505.
17. F. Schilling, S. Kessler, SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases, Z. Rheumatol. 59 (1) (Feb. 2000) 1-28.
18. O. Vittecoq, L.A. Said, C. Michot, O. Mejjad, J.M. Thomine, P. Mitrofanoff, J. Lechevallier, P. Ledosseur, A. Gayet, P. Lauret, X. le Loët, Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term, Arthritis Rheum. 43 (1) (Jan. 2000) 109-119.
19. A.F. Jansson, T.H. Müller, L. Gliera, D.P. Ankerst, U. Wintergerst, B.H. Belohradsky, V. Jansson, Clinical score for nonbacterial osteitis in children and adults, Arthritis Rheum. 60 (4) (Apr. 2009) 1152-1159.
20. G. Khanna, T.S.P. Sato, P. Ferguson, Imaging of chronic recurrent multifocal osteomyelitis1, Radiographics 29 (4) (Jul. 2009) 1159-1177.
21. A.G. Jurik, N. Egund, MRI in chronic recurrent multifocal osteomyelitis, Skeletal Radiol. 26 (4) (Apr. 1997) 230-238.
22. J. Fritz, N. Tzaribatchev, C.D. Claussen, J.A. Carrino, M.S. Horger, Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data, Radiology 252 (3) (Aug. 2009) 842-851.
23. H. Morbach, P. Schneider, T. Schwarz, C. Hofmann, P. Raab, H. Neubauer, C. Düren, M. Beer, H.J. Girschick, Comparison of magnetic resonance imaging and 99mTechnetium-labelledmethylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents, Clin. Exp. Rheumatol. 30 (4) (Jun. 2012) 578-582.
24. H. Neubauer, L. Evangelista, H. Morbach, H. Girschick, M. Prelog, H. Köstler, D. Hahn, M. Beer, Diffusion-weighted MRI of bone marrow oedema, soft tissue oedema and synovitis in paediatric patients: feasibility and initial experience, Pediatr. Rheumatol. Online J. 10 (1) (Jul. 2012) 20.
25. F. Schilling, S. Kessler, Chronic recurrent multifocal osteomyelitis-I. Review, Klin. Padiatr. 213 (5) (Aug. 2001) 271-276.
26. M. Twilt, R.M. Laxer, Clinical care of children with sterile bone inflammation, Curr.Opin. Rheumatol.23 (5) (Sep. 2011) 424-431.
27. C. Beck, H. Morbach, M. Beer, M. Stenzel, D. Tappe, S. Gattenlöhner, U. Hofmann, P. Raab, H.J. Girschick, Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment, Arthritis Res. Ther. 12 (2) (2010) R74.
28. Eleftheriou, T. Gerschman, N. Sebire, P. Woo, C.A. Pilkington, P.A. Brogan, Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood, Rheumatology 49 (8) (Aug. 2010) 1505-1512.
29. P.J. Ferguson, M. Sandu, Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis, Curr. Rheumatol. Rep. 14 (2) (Apr. 2012) 130-141.
30. T. Hospach, M. Langendoerfer, T. von Kalle, J. Maier, G.E. Dannecker, Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate, Eur. J. Pediatr. 169 (9) (Sep. 2010) 1105-1111.
31. P.M. Miettunen, X. Wei, D. Kaura, W.A. Reslan, A.N. Aguirre, J.D. Kellner, Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO), Pediatr. Rheumatol. Online J. 7 (2009) 2.
32. P.J. Simm, R.C. Allen, M.R. Zacharin, Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis, J. Pediatr. 152 (4) (Apr. 2008) 571-575.
33. H. Morbach, M. Stenzel, H.J. Girschick, Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis, Nat. Clin. Pract. Rheumatol. 4 (11) (Sep. 2008) 570-571.
34. S.R. Hofmann, T. Schwarz, J.C. Möller, H. Morbach, A. Schnabel, A. Rösen-Wolff, H.J. Girschick, C.M. Hedrich, Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression, Clin. Immunol. 141 (3) (Dec. 2011) 317-327.
35. S.R. Hofmann, H. Morbach, T. Schwarz, A. Rösen-Wolff, H.J. Girschick, C.M. Hedrich, Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression, Clin. Immunol. 145 (1) (Aug. 2012) 69-76.
36. S.R. Hofmann, A. Rösen-Wolff, G.C. Tsokos, C.M. Hedrich, Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury, Clin. Immunol. 143 (2) (May 2012) 116-127.
37. S.R. Hofmann, A. Roesen-Wolff, G. Hahn, C.M. Hedrich, Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO), Int. J. Rheumatol. 2012 (2012) 310206.
38. A. Golla, A. Jansson, J. Ramser, H. Hellebrand, R. Zahn, T. Meitinger, B.H. Belohradsky, A. Meindl, Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22, Eur. J. Hum. Genet. 10 (3) (Mar. 2002) 217-221.
39. M. Hurtado-Nedelec, S. Chollet-Martin, D. Chapeton, J.-P. Hugot, G. Hayem, B. Gérard, Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes, J. Rheumatol. 37 (2) (Feb. 2010) 401-409.
40. C. Beck, H.J. Girschick, H. Morbach, T. Schwarz, T. Yimam, J. Frenkel, M.E. van Gijn, Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence, Clin. Exp. Rheumatol. 29 (6) (Oct. 2011) 1040-1043.
41. J. Hamel, D. Paul, M. Gahr, C.M. Hedrich, Pilot study: possible association of IL10 promoter polymorphisms with CRMO, Rheumatol. Int. 32 (2) (Feb. 2012) 555-556.
42. H.A. Majeed, M. Kalaawi, D. Mohanty, A.S. Teebi, M.F. Tunjekar, F. al-Gharbawy, S.A. Majeed, A.H. al-Gazzar, Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings, J. Pediatr. 115 (5) (Nov. 1989) 730-734.
43. Z.S. Al-Mosawi, K.K. Al-Saad, R. Ijadi-Maghsoodi, H.I. El-Shanti, P.J. Ferguson, A splice site mutation confirms the role ofLPIN2 in Majeed syndrome, Arthritis Rheum. 56 (3) (2007) 960-964.
44. Ferguson, Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome), J. Med. Genet. 42 (7) (Jul. 2005) 551-557.
45. T. Herlin, B. Fiirgaard, M. Bjerre, G. Kerndrup, H. Hasle, X. Bing, P.J. Ferguson, Efficacy of anti-IL-1 treatment in Majeed syndrome, Ann. Rheum. Dis. (Oct. 2012).
46. J. Donkor, P. Zhang, S. Wong, L. O'Loughlin, J. Dewald, B.P.C. Kok, D.N. Brindley, K. Reue, A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2, J. Biol. Chem. 284 (43) (Oct. 2009) 29968-29978.
47. C.N. Lumeng, A.R. Saltiel, Inflammatory links between obesity and metabolic disease, J. Clin. Invest. 121 (6) (Jun. 2011) 2111-2117.
48. M. Valdearcos, E. Esquinas, C. Meana, L. Peña, L. Gil-de-Gómez, J. Balsinde, M.A. Balboa, Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages, J. Biol. Chem. 287 (14) (Mar. 2012) 10894-10904.
49. V. Chitu, P.J. Ferguson, R. de Bruijn, A.J. Schlueter, L.A. Ochoa, T.J. Waldschmidt, Y.G. Yeung, E.R. Stanley, Primed innate immunity leads to autoinflammatory disease in PSTPIP2- deficient cmo mice, Blood 114 (12) (Sep. 2009) 2497-2505.
50. P.J. Ferguson, X. Bing, M.A. Vasef, L.A. Ochoa, A. Mahgoub, T.J. Waldschmidt, L.T. Tygrett, A.J. Schlueter, H. El-Shanti, A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis, Bone 38 (1) (Jan. 2006) 41-47.
51. V. Chitu, V. Nacu, J.F. Charles, W.M. Henne, H.T. McMahon, S. Nandi, H. Ketchum, R. Harris, M.C. Nakamura, E.R. Stanley, PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts, Blood 120 (15) (Oct. 11, 2012) 3126-3135.
52. J. Grosse, Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease, Blood 107 (8) (Apr. 2006) 3350-3358.
53. T.A. Hentunen, S.J. Choi, B.F. Boyce, M.R. Dallas, S.L. Dallas, G.L. Shen-Ong, G.D. Roodman, A murine model of inflammatory bone disease, Bone 26 (2) (Feb. 2000) 183-188.
54. L. Byrd, M. Grossmann, M. Potter, G.L. Shen-Ong, Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse, Genomics 11 (4) (Dec. 1991) 794-798.
55. N.M. Lindor, T.M. Arsenault, H. Solomon, C.E. Seidman, M.T. McEvoy, A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome, Mayo Clin. Proc. 72 (7) (Jul. 1997) 611-615.
56. E.J. Smith, F. Allantaz, L. Bennett, D. Zhang, X. Gao, G. Wood, D.L. Kastner, M. Punaro, I. Aksentijevich, V. Pascual, C.A. Wise, Clinical, molecular, and genetic characteristics of PAPA syndrome: a review, Curr. Genomics 11 (7) (Nov. 2010) 519-527.
57. C.A. Wise, J.D. Gillum, C.E. Seidman, N.M. Lindor, R. Veile, S. Bashiardes, M. Lovett, Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder, Hum. Mol. Genet. 11 (8) (Apr. 2002) 961-969.
58. M.F. McDermott, A common pathway in periodic fever syndromes, Trends Immunol. 25 (9) (Sep. 2004) 457-460.
59. I. Aksentijevich, S.L. Masters, P.J. Ferguson, P. Dancey, J. Frenkel, A. van Royen-Kerkhoff, R. Laxer, U. Tedgård, E.W. Cowen, T.-H. Pham, M. Booty, J.D. Estes, N.G. Sandler, N. Plass, D.L. Stone, M.L. Turner, S. Hill, J.A. Butman, R. Schneider, P. Babyn, H.I. El-Shanti, E. Pope, K. Barron, X. Bing, A. Laurence, C.-C.R. Lee, D. Chapelle, G.I. Clarke, K. Ohson, M. Nicholson, M. Gadina, B. Yang, B.D. Korman, P.K. Gregersen, P.M. van Hagen, A.E. Hak, M. Huizing, P. Rahman, D.C. Douek, E.F. Remmers, D.L. Kastner, R. Goldbach-Mansky, An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist, N. Engl. J. Med. 360 (23) (Jun. 2009) 2426-2437.
60. S. Reddy, S. Jia, R. Geoffrey, R. Lorier, M. Suchi, U. Broeckel, M.J. Hessner, J. Verbsky, An autoinflammatory disease due to homozygous deletion of the IL1RN locus, N. Engl. J. Med. 360 (23) (Jun. 2009) 2438-2444.
61. I. Aksentijevich, M. Nowak, M. Mallah, J.J. Chae, W.T. Watford, S.R. Hofmann, L. Stein, R. Russo, D. Goldsmith, P. Dent, H.F. Rosenberg, F. Austin, E.F. Remmers, J.E. Balow, S. Rosenzweig, H. Komarow, N.G. Shoham, G. Wood, J. Jones, N. Mangra, H. Carrero, B.S. Adams, T.L. Moore, K. Schikler, H. Hoffman, D.J. Lovell, R. Lipnick, K. Barron, J.J. O'Shea, D.L. Kastner, R. Goldbach-Mansky, De novo CIAS1mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases, Arthritis Rheum. 46 (12) (Dec. 2002) 3340-3348.
62. A.A. Jesus, M. Osman, C.A. Silva, P.W. Kim, T.-H. Pham, M. Gadina, B. Yang, D.R. Bertola, M. Carneiro-Sampaio, P.J. Ferguson, B.R. Renshaw, K. Schooley, M. Brown, A. Al-Dosari, J. Al-Alami, J.E. Sims, R. Goldbach-Mansky, H. El-Shanti, A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: Description of two unrelated cases from Brazil, Arthritis Rheum. 63 (12) (Nov. 2011) 4007-4017.
63. M. Stenerson, K. Dufendach, I. Aksentijevich, J. Brady, J. Austin, A.M. Reed, The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist, Arthritis Rheum. 63 (12) (Dec. 2011) 4018-4022.
64. A. Onoufriadis, M.A. Simpson, A.E. Pink, P. Di Meglio, C.H. Smith, V. Pullabhatla, J. Knight, S.L. Spain, F.O. Nestle, A.D. Burden, F. Capon, R.C. Trembath, J.N. Barker, Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis, Am. J. Hum. Genet. 89 (3) (Sep. 2011) 432-437.
65. M.E. Papadaki, S.A. Lietman, M.A. Levine, B.R. Olsen, L.B. Kaban, E.J. Reichenberger, Cherubism: best clinical practice, Orphanet J. Rare Dis. 7 (1) (May 2012) S6.
66. Y. Ueki, V. Tiziani, C. Santanna, N. Fukai, C. Maulik, J. Garfinkle, C. Ninomiya, C. doAmaral, H. Peters, M. Habal, L. Rhee-Morris, J.B. Doss, S. Kreiborg, B.R. Olsen, E. Reichenberger, Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism, Nat. Genet. 28 (2) (Jun. 2001) 125-126.
67. C. Beneteau, H. Cavé, A. Moncla, N. Dorison, A. Munnich, A. Verloes, B. Leheup, SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions, Eur. J. Hum. Genet. 17 (10) (Oct. 2009) 1216-1221.
68. T. Jafarov, N. Ferimazova, E. Reichenberger, Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism, Clin. Genet. 68 (2) (Aug. 2005) 190-191.
69. N. Hanna, B. Parfait, I.M. Talaat, M. Vidaud, H.H. Elsedfy, SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome, Clin. Genet. 75 (6) (Jun. 2009) 568-571.
70. C.I. van Capelle, P.H.G. Hogeman, C.J.M. van der Sijs-Bos, B.G.F. Heggelman, B. Idowu, P.J. Slootweg, A.R.M. Wittkampf, A.M. Flanagan, Neurofibromatosis presenting with a cherubism phenotype, Eur. J. Pediatr. 166 (9) (Sep. 2007) 905-909.
71. E.J. Reichenberger, M.A. Levine, B.R. Olsen, M.E. Papadaki, S.A. Lietman, The role of SH3BP2 in the pathophysiology of cherubism, Orphanet J. Rare Dis. 7 (1) (May 2012) S5.
72. A. GuezGuez, V. Prod'homme, X. Mouska, A. Baudot, C. Blin-Wakkach, R. Rottapel, M. Deckert, 3BP2 Adapter protein is required for receptor activator of NFkappaB ligand (RANKL)- induced osteoclast differentiation of RAW264.7 cells, J. Biol. Chem. 285 (27) (Jul. 2010) 20952-20963.
73. Y. Ueki, C.-Y. Lin, M. Senoo, T. Ebihara, N. Agata, M. Onji, Y. Saheki, T. Kawai, P.M. Mukherjee, E. Reichenberger, B.R. Olsen, Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 'cherubism' mice, Cell 128 (1) (Jan. 2007) 71-83.
74. S. Guettler, J. LaRose, E. Petsalaki, G. Gish, A. Scotter, T. Pawson, R. Rottapel, F. Sicheri, Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease, Cell 147 (6) (Dec. 2011) 1340-1354.
75. N. Levaot, O. Voytyuk, I. Dimitriou, F. Sircoulomb, A. Chandrakumar, M. Deckert, P.M. Krzyzanowski, A. Scotter, S. Gu, S. Janmohamed, F. Cong, P.D. Simoncic, Y. Ueki, J. La Rose, R. Rottapel, Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism, Cell 147 (6) (Dec. 2011) 1324-1339.
76. C. Beck, H. Morbach, M. Stenzel, P. Schneider, H. Collmann, G. Girschick, H.J. Girschick, Hypophosphatasie, Klin. Padiatr. 221 (4) (Jul. 2009) 219-226.
77. M.P. Whyte, Physiological role of alkaline phosphatase explored in hypophosphatasia, Ann. N. Y. Acad. Sci. 1192 (Mar. 2010) 190-200.
78. E. Mornet, C. Beck, A. Bloch-Zupan, H. Girschick, M. Le Merrer, Clinical utility gene card for: hypophosphatasia, Eur. J. Hum. Genet. 19 (3) (Mar. 2011).
79. H.J. Girschick, E. Mornet, M. Beer, M. Warmuth-Metz, P. Schneider, Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy, BMC Pediatr. 7 (2007) 3.
80. M.P. Whyte, D. Wenkert, W.H. McAlister, M.Z. Mughal, A.J. Freemont, R. Whitehouse, E.M. Baildam, S.P. Coburn, L.M. Ryan, S. Mumm, Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia, J. Bone Miner. Res. 24 (8) (Aug. 2009) 1493-1505.
81. H.J. Girschick, P. Schneider, I. Haubitz, O. Hiort, H. Collmann, M. Beer, Y.S. Shin, H.W. Seyberth, Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia, Orphanet J. Rare Dis. 1 (2006) 24.
82. C. Beck, H. Morbach, P. Richl, M. Stenzel, H.J. Girschick, How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases? Rheumatol. Int. 29 (3) (Sep. 2008) 229-238.
83. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, J. Tschopp, Goutassociated uric acid crystals activate the NALP3 inflammasome, Nature 440 (7081) (Mar. 2006) 237-241.
84. C. Beck, H. Morbach, C. Wirth, M. Beer, H.J. Girschick, Whole-body MRI in the childhood form of hypophosphatasia, Rheumatol. Int. 31 (10) (Oct. 2011) 1315-1320.
85. M.P. Whyte, C.R. Greenberg, N.J. Salman, M.B. Bober, W.H. McAlister, D. Wenkert, B.J. Van Sickle, J.H. Simmons, T.S. Edgar, M.L. Bauer, M.A. Hamdan, N. Bishop, R.E. Lutz, M. McGinn, S. Craig, J.N. Moore, J.W. Taylor, R.H. Cleveland,W.R. Cranley, R. Lim, T.D. Thacher, J.E. Mayhew, M. Downs, J.L. Millán, A.M. Skrinar, P. Crine, H. Landy, Enzyme-replacement therapy in life-threatening hypophosphatasia, N. Engl. J. Med. 366 (10) (Mar. 2012) 904-913.
86. K.A. Blackwell, L.G. Raisz, C.C. Pilbeam, Prostaglandins in bone: bad cop, good cop? Trends Endocrinol. Metab. 21 (5) (May 2010) 294-301.
87. M. Castori, L. Sinibaldi, R. Mingarelli, R.S. Lachman, D.L. Rimoin, B. Dallapiccola, Pachydermoperiostosis: an update, Clin. Genet. 68 (6) (Dec. 2005) 477-486.
88. S. Uppal, C.P. Diggle, I.M. Carr, C.W.G. Fishwick, M. Ahmed, G.H. Ibrahim, P.S. Helliwell, A. Latos-Bielenska, S.E.V. Phillips, A.F. Markham, C.P. Bennett, D.T. Bonthron, Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy, Nat. Genet. 40 (6) (May 2008) 789-793.
89. B. Yüksel-Konuk, A. Sirmaci, G.E. Ayten, M. Özdemir, I. Aslan, Ü. Yilmaz-Turay, Y. Erdogan, M. Tekin, Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy, Rheumatol. Int. 30 (1) (Mar. 2009) 39-43.
90. C.P. Diggle, I.M. Carr, E. Zitt, K. Wusik, R.J. Hopkin, C.E. Prada, O. Calabrese, O. Rittinger, M.G. Punaro, A.F. Markham, D.T. Bonthron, Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy, Rheumatology 49 (6) (May 2010) 1056-1062.
91. C. Bergmann, M. Wobser, H. Morbach, A. Falkenbach, D. Wittenhagen, L. Lassay, H. Ott, K. Zerres, H.J. Girschick, H. Hamm, Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations, Exp. Dermatol. 20 (6) (Mar. 2011) 531-533.
92. Z. Zhang, W. Xia, J. He, Z. Zhang, Y. Ke, H. Yue, C. Wang, H. Zhang, J. Gu, W. Hu, W. Fu, Y. Hu, M. Li, Y. Liu, Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy, Am. J. Hum. Genet. 90 (1) (Jan. 2012) 125-132.
93. W. Seifert, J. Kühnisch, B. Tüysüz, C. Specker, A. Brouwers, D. Horn, Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing, Hum. Mutat. 33 (4) (Feb. 2012) 660-664.
94. J. Busch, V. Frank, N. Bachmann, A. Otsuka, V. Oji, D. Metze, K. Shah, S. Danda, B.Watzer, H. Traupe, H.J. Bolz, K. Kabashima, C. Bergmann, Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing, J. Investig. Dermatol. (Jun. 2012) 1-4.
95. C.P. Diggle, D.A. Parry, C.V. Logan, P. Laissue, C. Rivera, C.M. Restrepo, D.J. Fonseca, J.E. Morgan, Y. Allanore, M. Fontenay, J. Wipff, M. Varret, L. Gibault, N. Dalantaeva, M. Korbonits, B. Zhou, G. Yuan, G. Harifi, K. Cefle, S. Palanduz, H. Akoglu, P.J. Zwijnenburg, K.D. Lichtenbelt, B. Aubry-Rozier, A. Superti-Furga, B. Dallapiccola, M. Accadia, F. Brancati, E.G. Sheridan, G.R. Taylor, I.M. Carr, C.A. Johnson, A.F. Markham, D.T. Bonthron, Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis, Hum. Mutat. 33 (8) (May 2012) 1175-1181.
96. A.K. Kalloghlian, H.H. Frayha, M.M. deMoor, Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion, Eur. J. Pediatr. 155 (3) (Mar. 1996) 173-174.
97. H.J. Girschick, R. Krauspe, A. Tschammler, H.I. Huppertz, Chronic recurrent osteomyelitis with clavicular involvement in children: diagnostic value of different imaging techniques and therapy with non-steroidal anti-inflammatory drugs, Eur. J. Pediatr. 157 (1) (Jan. 1998) 28-33.